Oliver Buck is a serial entrepreneur with decades of track record in innovation, technology development, and the building of technology companies. In 2004, he founded ITM Isotope Technologies Munich SE in collaboration with the Technical University of Munich. Since then, ITM became a global leader in next-generation medical isotopes and theranostics. In 2012, he transitioned from his position as CEO of ITM to the supervisory Board and continues to actively support ITM and the growing theranostics industry at large in their strategic development. In 2018, he initiated and co-founded the ICPO Foundation with the aim help build momentum for Radiotheranostics in cancer care worldwide and scale global patient access to this innovative therapy. His global network, expertise in technology development and his ability to identify challenges and solutions well before they become obvious or critical are invaluable to the strategic direction of the ICPO Foundation.
